Cargando…

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer

The aim of this study was to investigate the impact of multileaf collimator width (MLC‐W) on intraprostatic dose painting plans for prostate cancer. Prostate cancer maps based on the histopathological findings were superimposed onto simulation CT images. Clinical target volume (CTV) 1 was defined as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, Eisuke, Mizowaki, Takashi, Norihisa, Yoshiki, Narita, Yuuichirou, Matsuo, Yukinori, Narabayashi, Masaru, Nagata, Yasushi, Hiraoka, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2010
Materias:	Radiation Oncology Physics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720410/ https://www.ncbi.nlm.nih.gov/pubmed/21081876 http://dx.doi.org/10.1120/jacmp.v11i4.3193

Ejemplares similares

Determination of Intraprostatic and Intratesticular Androgens
por: Šimková, Markéta, et al.
Publicado: (2021)

Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using (68)Ga- PSMA PET/CT
por: Bamneshin, Khadijeh, et al.
Publicado: (2022)

Volumetric and Voxel-Wise Analysis of Dominant Intraprostatic Lesions on Multiparametric MRI
por: Lee, Joon, et al.
Publicado: (2019)

Intraprostatic Hydatid Cyst: An Unusual Presentation
por: Nouira, Yassine, et al.
Publicado: (2006)

Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI
por: Harvey, Hugh, et al.
Publicado: (2017)

The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells
por: Nickols, Nicholas G., et al.
Publicado: (2020)

The Role of Intraprostatic Inflammation in the Acute Urinary Retention
por: Asgari, Seyed Alaeddin, et al.
Publicado: (2011)

Quantification of the margin required for treating intraprostatic lesions
por: Studenski, Matthew T., et al.
Publicado: (2016)

Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review
por: Feutren, Thomas, et al.
Publicado: (2018)

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
por: Goodman, Christopher D., et al.
Publicado: (2019)

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

Prediction and Mapping of Intraprostatic Tumor Extent with Artificial Intelligence
por: Priester, Alan, et al.
Publicado: (2023)

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
por: Zhou, Jun, et al.
Publicado: (2021)

Differences in the dose–volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer
por: Ueki, Nami, et al.
Publicado: (2013)

The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
por: Kwon, Young Kee, et al.
Publicado: (2010)

Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009)

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
por: Kazi, Aleksandra, et al.
Publicado: (2010)

Prostate Stereotactic Ablative Radiation Therapy Using Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions()
por: Murray, Louise J., et al.
Publicado: (2014)

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy
por: Chapman, Christopher H, et al.
Publicado: (2018)

Midline intraprostatic cyst: An unusual cause of lower urinary tract symptoms
por: Nayyar, Rishi, et al.
Publicado: (2008)

Stereological comparison of intraprostatic injection of alcohol and bleomycin with finasteride gavages in rats
por: Eslahi, Ali, et al.
Publicado: (2017)

Use of a multileaf collimator to increase the field width achievable with a dynamic wedge
por: Brezovich, Ivan A., et al.
Publicado: (2006)

Acute pyelonephritis revealing an intraprostatic obstructive megaureter in an adult: A rare finding
por: Kassir, Rani, et al.
Publicado: (2018)

Intraprostatic ozone therapy: A minimally invasive approach in benign prostatic hyperplasia
por: Hussain, Shabbir, et al.
Publicado: (2017)

Tissue distribution of ethanol after intraprostatic injection using a porous needle
por: Eubank, Megan N., et al.
Publicado: (2023)

3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study
por: Rischke, Hans Christian, et al.
Publicado: (2013)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer
por: Vavassori, A, et al.
Publicado: (2009)

Intraprostatic Injection of Alcohol Gel for the Treatment of Benign Prostatic Hyperplasia: Preliminary Clinical Results
por: Larson, Benjamin T., et al.
Publicado: (2006)

Intraprostatic injection of tranexamic acid to control refractory bleeding while maintaining therapeutic anticoagulation
por: Le, Brian, et al.
Publicado: (2019)

Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes
por: Cozzi, Salvatore, et al.
Publicado: (2023)

Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study
por: Ong, Ashley Li Kuan, et al.
Publicado: (2023)

Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009)

Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
por: Hsu, Yu-Chao, et al.
Publicado: (2016)

Characterization of the Halcyon(TM) multileaf collimator system
por: Lim, Tze Yee, et al.
Publicado: (2019)

Rounded leaf end effect of multileaf collimator on penumbra width and radiation field offset: an analytical and numerical study
por: Zhou, Dong, et al.
Publicado: (2015)

Stereotactic IMRT for prostate cancer: Dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT
por: Wang, L., et al.
Publicado: (2004)

Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer
por: Moreau, Juliette, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lc7ccl201tc3kdi2g48evuv1nu